5 studies were found.

1.		No longer recruiting	Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients with Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate Condition: Rheumatoid Arthritis
2.		No longer recruiting	Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma Conditions: Melanoma; Malignant Metastatic Melanoma
3.		Recruiting	MEDI-522 in the Treatment of Patients with Metastatic Androgen-Independent Prostate Cancer Condition: Prostate Cancer
4.		Recruiting	Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients with Acute Myeloid Leukemia Conditions: Leukemia; Acute Myeloid Leukemia
5.		Recruiting	Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients with Unresectable Non-Small Cell Lung Cancer Conditions: Esophagitis; Pneumonitis; Non-small cell lung cancer